NCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
Clinical Trials
8 trialsNCT03848182 2024-04-18
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT02700841 2024-03-12
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
University of Nebraska
Phase 2 Terminated
NCT03251924 2023-02-28
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT02864368 2022-06-09
PERFORMANCE
Duke University
Phase 1 Terminated
NCT02737475 2022-01-25
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
Phase 1/2 Completed
NCT03615404 2021-01-28
ATTAC-P
Duke University
Phase 1 Completed
NCT01611298 2020-04-21
TAR
Baylor College of Medicine
Phase NA Completed